Coronavirus (COVID-19) Q&A

Latest Episodes:

Coronavirus Update With Rochelle Walensky, MD, MPH Oct 26, 2020

Show notes

Rochelle P. Walensky, MD, MPH, of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to manage the spread of COVID-19. Recorded October 22, 2020.

Related Article(s):

Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions

The Costs of Coronavirus Oct 22, 2020

Show notes

The costs of the coronavirus pandemic are unprecedented in their dimensions: David M. Cutler, PhD, of Harvard University discusses financial costs: the $16 trillion virus.

Lisa Cooper, MD, MPH, of Johns Hopkins University discusses the costs to communities of color in excess deaths and bereavement.

Charles R. Marmar, MD, of NYU Grossman School of Medicine discusses the mental health costs. Recorded October 20, 2020.

Related Article(s):

The COVID-19 Pandemic and the $16 Trillion Virus

Coronavirus Q&A With Andy Slavitt, MBA Oct 21, 2020

Show notes

Andy Slavitt, MBA, discusses recent developments in the COVID-19 pandemic and the US response. Slavitt is former Acting CMS Administrator in the Obama administration, board director at the United States of Care in Washington, DC, and a Distinguished Health Policy Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania in Philadelphia. Recorded October 16, 2020.

The COVID-19 Pandemic Underscores the Need to Address Structural Challenges of the US Health Care System

Can We Count on Herd Immunity to Control COVID-19? Oct 19, 2020

Show notes

Many people are hoping that enough people develop resistance to COVID-19, either from being exposed to the disease or from vaccination, to develop herd immunity that will enable society to return to normal. But will that happen? Saad Omer, MD, from the Yale Institute for Global Health, discusses his JAMA article on herd immunity and how much we can count on having it to return society to normal from this COVID-19 pandemic.

Related Article(s):

Herd Immunity and Implications for SARS-CoV-2 Control

Prioritizing Racial and Ethnic Minority Populations for Coronavirus Vaccination Oct 16, 2020

Show notes

The National Academy of Medicine has recommended that racial minority populations receive priority for vaccination because they have been hard hit by the pandemic and are "worse off" socioeconomically. US law is inconsistent on whether race/ethnicity can be an explicit criterion for achieving equity and diversity. Lawrence O. Gostin, JD, of Georgetown University and Michelle A. Williams, ScD, of Harvard T.H. Chan School of Public Health discuss ways to achieve the public health objective of protecting vulnerable communities while adhering to law and ethics. Recorded October 14, 2020.

Related Article(s):

Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?

Digging Into Obesity's COVID-19 Risks Oct 15, 2020

Show notes

University of North Carolina (UNC) at Chapel Hill nutrition scholar Barry Popkin, PhD, and JAMA Medical News Associate Managing Editor Jennifer Abbasi discuss new findings on obesity and COVID-19. Popkin is the lead author of a systematic review and meta-analysis on the topic that was published recently in Obesity Reviews. He is a distinguished professor in the department of nutrition at the UNC Gillings School of Global Public Health.

Related Article(s):

Large Meta-analysis Digs Into Obesity's COVID-19 Risks

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic Oct 15, 2020

Show notes

Interview with Christopher W. Seymour, MD, MSc, author of Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

Related Article(s):

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

Who Gets Coronavirus Vaccine First? Oct 07, 2020

Show notes

On October 2 the US National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, cochaired the committee that authored the report and discusses its recommendations. Recorded October 2, 2020.

Fairly Prioritizing Groups for Access to COVID-19 Vaccines

Coronavirus Vaccine Update From the FDA Oct 07, 2020

Show notes

Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an update on vaccine progress to date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.

Related Article(s):

Unwavering Regulatory Safeguards for COVID-19 Vaccines

US Adults' Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019 Oct 06, 2020

Show notes

Sarah E. Gollust, PhD joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study examining public perception of high priority groups for receipt of an eventual coronavirus disease 2019 vaccine in case of shortage of supply. Read the article here: https://ja.ma/3d2101T.

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Coronavirus (COVID-19) Q&A

Related Podcasts

Links

Stay Connected